COMPASS Pathways Partners with Worldwide Clinical Trials to Conduct World’s First Large-scale Clinical Trials in Psilocybin Therapy for Treatment-resistant Depression
Wednesday, 6 December 2017 LONDON & MORRISVILLE, N.C.--(BUSINESS WIRE)--COMPASS Pathways is partnering with Worldwide Clinical Trials to conduct clinical trials in psilocybin therapy for treatment-resistant depression.
PARIS — French man Jérôme Hamon has become the world's first patient to undergo two face transplants. He suffers from neurofibromatosis type 1.
According to the Mayo Clinic, Neurofibromatosis 1,.. Source: TomoNews US -
Lower back pain is the world's leading cause of disability globally. according to new research, the condition is being improperly treated with pain medication instead of physical therapy and exercise... Source: Wochit News -
A federal agency is recruiting volunteers for a study seeking a vaccine against H7N9. H7N9 is a strain of avian influenza that has not reached humans in the United States--yet. The National Institutes.. Source: Wochit News -